{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:34:01Z","timestamp":1774283641183,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Ministry of Education of Thailand and Thammasat University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1181-1","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T13:48:08Z","timestamp":1456753688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border"],"prefix":"10.1186","volume":"15","author":[{"given":"Richard","family":"H\u00f6glund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younis","family":"Moussavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnatrai","family":"Ruengweerayut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurak","family":"Cheomung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"\u00c4bel\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesara","family":"Na-Bangchang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"1181_CR1","volume-title":"World Malaria Report","author":"WHO","year":"2014","unstructured":"WHO. World Malaria Report. Geneva: World Health Organization; 2014."},{"key":"1181_CR2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.trstmh.2006.06.008","volume":"101","author":"A Ratcliff","year":"2007","unstructured":"Ratcliff A, Siswantoro H, Kenangalem E, Wuwung M, Brockman A, Edstein MD, et al. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans R Soc Trop Med Hyg. 2007;101:351\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1181_CR3","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1371\/journal.pmed.0050128","volume":"5","author":"E Tjitra","year":"2008","unstructured":"Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5:e128.","journal-title":"PLoS Med"},{"key":"1181_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-3156.2005.01557.x","volume":"11","author":"S Vijaykadga","year":"2006","unstructured":"Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health. 2006;11:211\u20139.","journal-title":"Trop Med Int Health"},{"key":"1181_CR5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.trstmh.2005.04.024","volume":"100","author":"O Tasanor","year":"2006","unstructured":"Tasanor O, Ruengweerayut R, Sirichaisinthop J, Congpuong K, Wernsdorfer WH, Na-Bangchang K. Clinical-parasitological response and in vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand. Trans R Soc Trop Med Hyg. 2006;100:410\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1181_CR6","doi-asserted-by":"crossref","first-page":"e14501","DOI":"10.1371\/journal.pone.0014501","volume":"6","author":"Y Poravuth","year":"2011","unstructured":"Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Pyae Phyo A, Valecha N, et al. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-interiority trial. PLoS One. 2011;6:e14501.","journal-title":"PLoS One"},{"key":"1181_CR7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1475-2875-10-44","volume":"10","author":"P Muhamad","year":"2011","unstructured":"Muhamad P, Ruengweerayut R, Chacharoenkul W, Rungsihirunrat K, Na-Bangchang K. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009\u20132010. Malar J. 2011;10:44.","journal-title":"Malar J"},{"key":"1181_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0001-706X(02)00090-6","volume":"83","author":"K Congpuong","year":"2002","unstructured":"Congpuong K, Na-Bangchang K, Thimasarn K, Tasanor U, Wernsdorfer WH. Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand. Acta Trop. 2002;83:117\u201321.","journal-title":"Acta Trop"},{"key":"1181_CR9","unstructured":"Bureau of Vector Borne Diseases DoDC, Ministry of Health. National Strategic Plan for Malaria Control and Elimination in Thailand; 2011."},{"key":"1181_CR10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJM199104113241506","volume":"324","author":"IK Schwartz","year":"1991","unstructured":"Schwartz IK, Lackritz EM, Patchen LC. Chloroquine-resistant Plasmodium vivax from Indonesia. N Eng J Med. 1991;324:927.","journal-title":"N Eng J Med"},{"key":"1181_CR11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(89)91792-3","volume":"2","author":"KH Rieckmann","year":"1989","unstructured":"Rieckmann KH, Davis DR, Hutton DC. Plasmodium vivax resistance to chloroquine? Lancet. 1989;2:1183\u20134.","journal-title":"Lancet"},{"key":"1181_CR12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0035-9203(89)90370-2","volume":"83","author":"GJ Schuurkamp","year":"1989","unstructured":"Schuurkamp GJ, Spicer PE, Kereu RK, Bulungol PK. A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report. Trans R Soc Trop Med Hyg. 1989;83:607\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1181_CR13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(89)92002-3","volume":"2","author":"M Whitby","year":"1989","unstructured":"Whitby M, Wood G, Veenendaal JR, Rieckmann K. Chloroquine-resistant Plasmodium vivax. Lancet. 1989;2:1395.","journal-title":"Lancet"},{"key":"1181_CR14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/infdis\/164.1.222","volume":"164","author":"P Collignon","year":"1991","unstructured":"Collignon P. Chloroquine resistance in Plasmodium vivax. J Infect Dis. 1991;164:222\u20133.","journal-title":"J Infect Dis"},{"key":"1181_CR15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4269\/ajtmh.1991.44.547","volume":"44","author":"JK Baird","year":"1991","unstructured":"Baird JK, Basri H, Purnomo Bangs MJ, Subianto B, Patchen LC, et al. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1991;44:547\u201352.","journal-title":"Am J Trop Med Hyg"},{"key":"1181_CR16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0140-6736(93)92568-E","volume":"341","author":"GS Murphy","year":"1993","unstructured":"Murphy GS, Basri H, Purnomo Andersen EM, Bangs MJ, Mount DL, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet. 1993;341:96\u2013100.","journal-title":"Lancet"},{"key":"1181_CR17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0035-9203(98)90966-X","volume":"92","author":"DJ Fryauff","year":"1998","unstructured":"Fryauff DJ, Soekartono Tuti S, Leksana B, Suradi Tandayu S, et al. Survey of resistance in vivo to chloroquine of Plasmodium falciparum and P. vivax in North Sulawesi, Indonesia. Trans R Soc Trop Med Hyg. 1998;92:82\u20133.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1181_CR18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4269\/ajtmh.2003.68.416","volume":"68","author":"IW Sumawinata","year":"2003","unstructured":"Sumawinata IW, Bernadeta Leksana B, Sutamihardja A, Purnomo Subianto B, et al. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am J Trop Med Hyg. 2003;68:416\u201320.","journal-title":"Am J Trop Med Hyg"},{"key":"1181_CR19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0035-9203(95)90556-1","volume":"89","author":"T Marlar","year":"1995","unstructured":"Marlar T. Myat Phone K, Aye Yu S, Khaing Khaing G, Ma S, Myint O. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans R Soc Trop Med Hyg. 1995;89:307\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1181_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0035-9203(93)90294-Z","volume":"87","author":"K Myat Phone","year":"1993","unstructured":"Myat Phone K, Myint O, Myint L, Thaw Z, Kyin Hla A, Nwe Nwe Y. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg. 1993;87:687\u201390.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1181_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-3156.2007.01978.x","volume":"13","author":"JP Guthmann","year":"2008","unstructured":"Guthmann JP, Pittet A, Lesage A, Imwong M, Lindegardh N, MinLwin M, et al. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar. Trop Med Int Health. 2008;13:91\u20138.","journal-title":"Trop Med Int Health"},{"key":"1181_CR22","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-3156.2002.00948.x","volume":"7","author":"GT Phan","year":"2002","unstructured":"Phan GT, de Vries PJ, Tran BQ, Le HQ, Nguyen NV, Nguyen TV, et al. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Trop Med Int Health. 2002;7:858\u201364.","journal-title":"Trop Med Int Health"},{"key":"1181_CR23","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria","author":"WHO","year":"2002","unstructured":"WHO. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organization; 2002."},{"key":"1181_CR24","first-page":"1031","volume":"55","author":"A Cheomung","year":"2011","unstructured":"Cheomung A, Na-Bangchang K. HPLC with ultraviolet detection for determination of chloroquine and desethylchloroquine in whole blood and finger-prick capillary blood dried on filter paper. J Pharm Bioanal. 2011;55:1031\u201340.","journal-title":"J Pharm Bioanal"},{"key":"1181_CR25","first-page":"195","volume":"8","author":"SL Beal","year":"1982","unstructured":"Beal SL, Sheiner LB. Estimating population kinetics. Crit Rev Biomed Eng. 1982;8:195\u2013222.","journal-title":"Crit Rev Biomed Eng"},{"key":"1181_CR26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1128\/AAC.01269-09","volume":"54","author":"H Karunajeewa","year":"2010","unstructured":"Karunajeewa H, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, et al. Pharmacokinetics of chloroquine and monodesethyl-chloroquine in pregnancy. Antimicrob Agents Chemother. 2010;54:1186\u201392.","journal-title":"Antimicrob Agents Chemother"},{"key":"1181_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.1988.tb03332.x","volume":"25","author":"G Edwards","year":"1988","unstructured":"Edwards G, Looareesuwan S, Davies AJ, Wattanagoon Y, Phillips RE, Warrell DA. Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria. Br J Clin Pharmacol. 1988;25:477\u201385.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2125.1987.tb03165.x","volume":"24","author":"LL Gustafsson","year":"1987","unstructured":"Gustafsson LL, Lindstr\u00f6m B, Grahn\u00e9n A, Alv\u00e1n G. Chloroquine excretion following malaria prophylaxis. Br J Clin Pharmacol. 1987;24:221\u20134.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR29","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/BF00541305","volume":"31","author":"SE Tett","year":"1987","unstructured":"Tett SE, Cutler DJ. Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times. Eur J Clin Pharmacol. 1987;31:729\u201331.","journal-title":"Eur J Clin Pharmacol"},{"key":"1181_CR30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.1988.tb03332.x","volume":"25","author":"EO Titus","year":"1988","unstructured":"Titus EO. Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine. Br J Clin Pharmacol. 1988;25:477\u201385.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00228-008-0500-z","volume":"64","author":"SJ Lee","year":"2008","unstructured":"Lee SJ, McGready R, Fernandez C, Stepniewska K, Paw MK, Viladpai-Nguen SJ, et al. Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria. Eur J Clin Pharmacol. 2008;64:987\u201392.","journal-title":"Eur J Clin Pharmacol"},{"key":"1181_CR32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2875-13-36","volume":"13","author":"Q Zhao","year":"2014","unstructured":"Zhao Q, Tensfeldt TG, Chandra R, Mould DR. Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets. Malar J. 2014;13:36.","journal-title":"Malar J"},{"key":"1181_CR33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/00034983.1984.11811868","volume":"78","author":"AF Aderounmu","year":"1984","unstructured":"Aderounmu AF. In vitro assessment of the antimalarial activity of chloroquine and its major metabolites. Ann Trop Med Parasitol. 1984;78:581\u20135.","journal-title":"Ann Trop Med Parasitol"},{"key":"1181_CR34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1983.tb01532.x","volume":"15","author":"LL Gustafsson","year":"1983","unstructured":"Gustafsson LL, Walker O, Alv\u00e1n G, Beermann B, Estevez F, Gleisner L, et al. Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol. 1983;15:471\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/AAC.00555-07","volume":"52","author":"HA Karunajeewa","year":"2008","unstructured":"Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, Page-Sharp M, et al. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother. 2008;52:237\u201343.","journal-title":"Antimicrob Agents Chemother"},{"key":"1181_CR36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2125.2007.03050.x","volume":"65","author":"C Obua","year":"2008","unstructured":"Obua C, Hellgren U, Ntale M, Gustafsson LL, Ogwal-Okeng JW, Gordi T, et al. Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen. Br J Clin Pharmacol. 2008;65:493\u2013501.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2125.1986.tb02935.x","volume":"22","author":"F Aderounmu","year":"1986","unstructured":"Aderounmu F, Salako L, Lindstr\u00f6m B, Walker O, Ekman L. Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol. 1986;22:559\u201364.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00542151","volume":"26","author":"M Frisk-Holmberg","year":"1984","unstructured":"Frisk-Holmberg M, Bergqvist Y, Termond E, Domeij-Nyberg B. The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects. Eur J Clin Pharmacol. 1984;26:521\u201330.","journal-title":"Eur J Clin Pharmacol"},{"key":"1181_CR39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-3156.2002.00899.x","volume":"7","author":"D Bustos","year":"2002","unstructured":"Bustos D, Lazaro J, Gay F. Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines. Trop Med Int Health. 2002;7:584\u201391.","journal-title":"Trop Med Int Health"},{"key":"1181_CR40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03259430","volume":"8","author":"PJ Vries","year":"1994","unstructured":"Vries PJ, Oosterhuis B, Boxtel C. Single-dose pharmacokinetics of chloroquine and its main metabolite in healthy volunteers. Drug Invest. 1994;8:143\u20139.","journal-title":"Drug Invest"},{"key":"1181_CR41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2125.1995.tb05731.x","volume":"39","author":"JC Wetsteyn","year":"1995","unstructured":"Wetsteyn JC, De Vries PJ, Oosterhuis B, Van Boxtel CJ. The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis. Br J Clin Pharmacol. 1995;39:696\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/dmd.31.6.748","volume":"31","author":"D Projean","year":"2003","unstructured":"Projean D, Baune B, Farinotti R. In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Disp. 2003;31:748\u201354.","journal-title":"Drug Metab Disp"},{"key":"1181_CR43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2125.1991.tb03904.x","volume":"32","author":"K Silamut","year":"1991","unstructured":"Silamut K, Molunto P, Ho M, Davis TM, White NJ. Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol. 1991;32:311\u20135.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2125.1991.tb03905.x","volume":"32","author":"SM Mansor","year":"1991","unstructured":"Mansor SM, Molyneux ME, Taylor TE, Ward SA, Wirima JJ, Edwards G. Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children. Br J Clin Pharmacol. 1991;32:317\u201321.","journal-title":"Br J Clin Pharmacol"},{"key":"1181_CR45","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.1946.02870290013005","volume":"131","author":"H Most","year":"1964","unstructured":"Most H, London IM, Kane CA, Lavietes PH, Schroeder EF, Hayman JM. Chloroquine for treatment of acute attacks of vivax malaria. J Am Med Assoc. 1964;131:963\u20137.","journal-title":"J Am Med Assoc"},{"key":"1181_CR46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archinte.1947.00220100015001","volume":"79","author":"HH Gordon","year":"1947","unstructured":"Gordon HH, Dieuaide FR, Marble A, Christianson HB, Dahl LK. Treatment of Plasmodium vivax malaria of foreign origin: a comparison of various drugs. Arch Intern Med. 1947;79:365\u201380.","journal-title":"Arch Intern Med"},{"key":"1181_CR47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4269\/ajtmh.1997.56.621","volume":"56","author":"JK Baird","year":"1997","unstructured":"Baird JK, Leksana B, Masbar S, Fryauff DJ, Sutanihardja MA, Suradi, et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg. 1997;56:621\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"1181_CR48","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/AAC.48.11.4075-4083.2004","volume":"11","author":"JK Baird","year":"2004","unstructured":"Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004;11:4075\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"1181_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12936-015-0774-4","volume":"14","author":"A A\u00f1ez","year":"2015","unstructured":"A\u00f1ez A, Moscoso M, Laguna A, Garnica C, Melgar V, Cuba M, et al. Resistance of infection by Plasmodium vivax to chloroquine in Bolivia. Malar J. 2015;14:261.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1181-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T03:24:24Z","timestamp":1567653864000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/15\/1\/129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1181-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]},"article-number":"129"}}